PIA
Petredis Investment Advisors’s SPDR S&P Biotech ETF XBI Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $4.58M | Buy |
55,170
+503
| +0.9% | +$41.7K | 0.4% | 56 |
|
2025
Q1 | $4.43M | Buy |
54,667
+1,018
| +2% | +$82.6K | 0.46% | 47 |
|
2024
Q4 | $4.83M | Sell |
53,649
-1,177
| -2% | -$106K | 0.5% | 42 |
|
2024
Q3 | $5.42M | Buy |
54,826
+122
| +0.2% | +$12.1K | 0.58% | 43 |
|
2024
Q2 | $5.07M | Sell |
54,704
-56
| -0.1% | -$5.19K | 0.57% | 44 |
|
2024
Q1 | $5.2M | Buy |
54,760
+1,336
| +3% | +$127K | 0.62% | 38 |
|
2023
Q4 | $4.77M | Sell |
53,424
-1,741
| -3% | -$155K | 0.63% | 39 |
|
2023
Q3 | $4.03M | Buy |
55,165
+72
| +0.1% | +$5.26K | 0.57% | 43 |
|
2023
Q2 | $4.58M | Sell |
55,093
-256
| -0.5% | -$21.3K | 0.63% | 40 |
|
2023
Q1 | $4.22M | Buy |
55,349
+708
| +1% | +$54K | 0.66% | 41 |
|
2022
Q4 | $4.54M | Buy |
+54,641
| New | +$4.54M | 0.82% | 35 |
|